Trials / Active Not Recruiting
Active Not RecruitingNCT03708965
An Extension Study of JR-141-BR21 in Patients With Mucopolysaccharidosis II
- Status
- Active Not Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 19 (actual)
- Sponsor
- JCR Pharmaceuticals Co., Ltd. · Industry
- Sex
- Male
- Age
- 0 Years
- Healthy volunteers
- Not accepted
Summary
A Phase II open-label, parallel group, 2 sites (Brazil), designed to evaluate the long term safety and efficacy of study drug for the treatment of the MPS II.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | JR-141 | IV infusion (lyophilized powder) |
Timeline
- Start date
- 2019-01-01
- Primary completion
- 2026-12-31
- Completion
- 2027-12-31
- First posted
- 2018-10-17
- Last updated
- 2025-07-24
Locations
2 sites across 1 country: Brazil
Source: ClinicalTrials.gov record NCT03708965. Inclusion in this directory is not an endorsement.